Difference between revisions of "Ifosfamide (Ifex)"

Revision as of 16:26, 3 December 2017

General information

Class/mechanism: Nitrogen mustard, alkylator. Metabolites of ifosfamide interact with DNA to produce phosphotriesters and formation of DNA cross-links. Ifosfamide requires metabolic activation by microsomal liver enzymes to form its active metabolites.^[1]^[2]
Route: IV
Extravasation: irritant or neutral, depending on reference

A protective agent such as Mesna (Mesnex) should be used concurrently with ifosfamide to help prevent hemorrhagic cystitis.

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.^[1]

Diseases for which it is used

Patient drug information

History of changes in FDA indication

12/30/1988: Initial FDA approval

Also known as

Synonyms
Alquimid	Duvaxan	Fentul	Fosfidex	Haloxan
Holoxan	Holoxane	Ifex	IFO Cell	Ifocris
Ifolem	Ifomida	Ifomide	Ifos	Ifosfamida Delta Farma
Ifosfamida Filaxis	Ifosfamida Microsules	Ifosfamida Servycal	Ifoxan	IFX
Ipamide	Isophosphamide	Isoxan	Macdafen	Mitoxana
Mitoxana Lyophilisate	PI FU Ping	Trav Ifosfamide	Tronoxal	Vero Ifosfamide

References

[insert-1] 1.0 ^1.1 Ifosfamide (Ifex) package insert

[2] Ifosfamide (Ifex) package insert (locally hosted backup)

[3] Ifosfamide (Ifex) patient drug information (Chemocare)

[4] Ifosfamide (Ifex) patient drug information (UpToDate)

[1]

[2]

[3]

[4]

@@ Line 6: / Line 6: @@
 *A protective agent such as [[Mesna (Mesnex)]] should be used concurrently with ifosfamide to help prevent hemorrhagic cystitis.
-For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer.  Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information.<ref name="insert"></ref>
+For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information.<ref name="insert"></ref>
 ==Diseases for which it is used==